We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Jupiter, Florida, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (Nasdaq: JUNS) (the “Company” or “Jupiter Neurosciences”), a clinical stage pharmaceutical company advancing a...
Jupiter, Florida, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (Nasdaq: JUNS) (the “Company” or “Jupiter Neurosciences”), a clinical stage pharmaceutical company advancing a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 11 | 19.51 | 7.5 | 394230 | 10.68469185 | CS |
4 | 7 | 175 | 4 | 19.51 | 3.89 | 516017 | 10.12194751 | CS |
12 | 7 | 175 | 4 | 19.51 | 3.89 | 516017 | 10.12194751 | CS |
26 | 7 | 175 | 4 | 19.51 | 3.89 | 516017 | 10.12194751 | CS |
52 | 7 | 175 | 4 | 19.51 | 3.89 | 516017 | 10.12194751 | CS |
156 | 7 | 175 | 4 | 19.51 | 3.89 | 516017 | 10.12194751 | CS |
260 | 7 | 175 | 4 | 19.51 | 3.89 | 516017 | 10.12194751 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions